The judge overseeing the marathon trial between agricultural giants Cargill and Viterra over the $420 million sale of malt producer Joe White has shot down objections to both parties’ expert reports related to whether it was common industry practice to cheat customers by failing to comply with contract details and providing misleading malt test results.
A judge has panned evidence put on by Fuchs Lubricants in a patent dispute with Quaker Chemical as “woefully inadequate” and “absolutely garbage”, partially shooting down the firm’s attempt to block discovery of allegedly privileged documents.
A judge has put a proposal for a common fund order in a class action against sandalwood producer Quintis on hold as the court awaits judgment in an historic challenge to the power of courts to make common fund orders.
Senator Michaelia Cash’s former media adviser says he notified his counterpart in the office of former federal Justice Minister Michael Keenan ahead of AFP raids on the Australian Workers’ Union offices, and both alerted the media, a court heard Wednesday.
Greens Senator Sarah Hanson-Young has slammed Liberal Democrat Senator David Leyonhjelm’s attempt to stay her defamation case against him without providing evidence that the alleged misandrist comments at the heart of the proceedings were spoken in Parliament.
A construction company has lost its appeal of a ruling that it illegally blocked CFMMEU officials from entering a work site to meet with union members, with a judge saying the union did not need to prove intent to obstruct to make its case for violations of the Fair Work Act.
Biotech company Cryosite has agreed to pay $1.05 million to settle the competition regulator’s landmark case alleging it jumped the gun on a proposed merger agreement with rival Cell Care.
A former Norton Rose Fulbright partner says he may file a contempt of court motion against the firm for allegedly failing to produce certain evidentiary documents for over two years.
Railway technology company Wavetrain Systems has asked the court to bar a competitor started by its former CEO from making allegedly false claims about its patented rail safety devices to clients.
A judge that rejected a bid by Sanofi-Aventis for an injunction blocking rival Alphapharm from listing an insulin injector pen on the PBS erred in his consideration of the harm it would face, the drug giant has told the Full Federal Court.